Colorado Capitol Watch
border Logo hdr_right_bottom

Bill Detail: SB20-007

Return to list of bills


Title Treatment Opioid And Other Substance Use Disorders
Status Senate Committee on Appropriations Refer Amended to Senate Committee of the Whole (03/13/2020)
Bill Subjects
  • Courts & Judicial
  • Health Care & Health Insurance
House Sponsors J. Wilson (R)
B. Buentello (D)
Senate Sponsors B. Pettersen (D)
F. Winter (D)
House Committee
Senate Committee Health and Human Services
Date Introduced 01/08/2020

Opioid and Other Substance Use Disorders Study Committee.
Section 1 of the bill requires updated community assessments every 2
years of the sufficiency of substance use disorder services in the
community to be compiled by an independent entity contracted by the
department of human services (DHS). The assessment must include input
and the opportunity for review and comment from community entities and
individuals. Based on the community assessment, the managed service
organization will prepare a draft community action plan and shall allow

time for stakeholder review and comment on the plan.
Section 2 of the bill requires insurance carriers to provide
coverage for the treatment of substance use disorders in accordance with
the American society of addiction medicine (ASAM) criteria for
placement, medical necessity, and utilization management determinations
in accordance with the most recent edition of the ASAM criteria. The bill
also authorizes the commissioner of insurance, in consultation with DHS
and the department of health care policy and financing, to identify by rule
alternate nationally recognized substance-use-disorder-specific treatment
criteria if the ASAM criteria are no longer available, relevant, or reflect
best practices.
Sections 3, 4, and 5 of the bill increases funding by $1 million for
provider loan forgiveness and scholarships from the Colorado health
service corps fund in the department of public health and environment
(CDPHE). The bill recognizes a goal of the loan forgiveness and
scholarship programs of creating a diverse health care workforce that is
able to address the needs of underserved populations and communities.
Section 6 of the bill authorizes a pharmacy that has entered into a
collaborative pharmacy agreement with one or more physicians to receive
an enhanced dispensing fee for the administration of all injectable
medications for medication-assisted treatment that are approved by the
federal food and drug administration, and not just injectable antagonist
Section 7 of the bill requires DHS to commission a state child care
and treatment study and final report to make findings and
recommendations concerning gaps in family-centered substance use
disorder treatment and to identify alternative payment structures for
funding child care and children's services alongside substance use
disorder treatment of a child's parent. DHS shall distribute the report to
the general assembly and present the report in its annual presentation to
committees of the general assembly.
Sections 8, 9, 10, 11, and 12 of the bill prohibit managed service
organization contracted providers; withdrawal management services; and
recovery residences from denying access to medical or substance use
disorder treatment services, including recovery services, to persons who
are participating in prescribed medication-assisted treatment for substance
use disorders. In addition, the bill prohibits courts and parole, probation,
and community corrections from prohibiting the use of prescribed
medication-assisted treatment as a condition of participation or
Section 13 of the bill requires managed care entities to provide
coordination of care for the full continuum of substance use disorder and
mental health treatment and recovery services, including support for
individuals transitioning between levels of care.
Section 14 of the bill appropriates $250,000 to the office of
behavioral health in DHS for allocation to the center for research into
substance use disorder prevention, treatment, and recovery support
strategies for the continued employment of grant writers to aid local
communities in need of assistance to access federal and state money to
address opioid and other substance use disorders in their communities.
Section 15 of the bill authorizes the commissioner of insurance,
in consultation with CDPHE, to promulgate rules, or to seek a revision of
the essential health benefits package, for prescription medications for
medication-assisted treatment to be included on insurance carriers'
Section 16 of the bill requires insurance carriers to report to the
commissioner of insurance on the number of in-network providers who
are licensed to prescribe medication-assisted treatment for substance use
disorders, including buprenorphine, and of that number, to indicate how
many providers are actively prescribing medication-assisted treatment.
The bill requires the commissioner of insurance to promulgate rules
concerning the reporting.
Section 17 of the bill requires insurance carriers to provide
coverage for naloxone hydrochloride, or other similarly acting drug,
without prior authorization and without imposing any deductible,
copayment, coinsurance, or other cost-sharing requirement.
Section 18 of the bill requires DHS to implement a program for
training and community outreach relating to, at a minimum, the
availability of and process for civil commitment of persons with an
alcohol or substance use disorder. The training must be provided to first
responders, law enforcement, emergency departments, primary care
providers, and persons and families of persons with a substance use
disorder, among others.
Sections 19 through 65 of the bill consolidate part 1 of article 82
of title 27, C.R.S., relating to emergency treatment and voluntary and
involuntary commitment of persons for treatment of drugs into the
existing part 1 of article 81 of title 27, C.R.S., relating to emergency
treatment and voluntary and involuntary commitment of persons for
treatment of alcohol use disorders, in order to create a single process that
includes all substances.
The new scope of part 1 of article 81 of title 27, C.R.S., includes
both alcohol use disorder and substance use disorder under the defined
term substance use disorder.
The amendments and additions to part 1 of article 81 of title 27,
C.R.S., include:
  • Defining administrator to include an administrator's
  • Adding a definition of incapacitated by substances to
include a person who is incapacitated by alcohol or
incapacitated by substances;
  • Changing terminology throughout to refer to substances
to include both alcohol and drugs;
  • Adjusting the duration of the initial involuntary
commitment from 30 days to up to 90 days;
  • Allowing a person to enter into a stipulated order for
committed treatment, expediting placement into treatment;
  • Removing the mandatory hearing for the initial involuntary
commitment but allowing a person to request a hearing if
the person does not want to enter into a stipulated order for
committed treatment;
  • Incorporating in statute patient's rights relating to civil
  • Using person-centered language throughout the statutory
process; and
  • Relocating the existing opioid crisis recovery funds
advisory committee from article 82 in title 27, C.R.S., to
article 81 in title 27, C.R.S.
In addition, the bill makes conforming amendments, including
several in the professional licensing statutes in title 12, C.R.S., to remove
references to both alcohol use disorder and substance use disorder as
grounds for professional discipline, and replaces those terms with the
single term substance use disorder,which the bill now defines in article
81 of title 27, C.R.S., to include both drugs and alcohol.
The bill also makes conforming amendments to remove statutory
references to provisions in part 2 of article 82 of title 27, C.R.S., which
the bill repeals, and replaces those references with a new reference to the
relevant provisions in article 81 of title 27, C.R.S.

Committee Reports
with Amendments
Full Text
Full Text of Bill (pdf) (most recent)
Fiscal Notes Fiscal Notes (03/11/2020) (most recent)  
Additional Bill Documents Bill Documents
  • Past bill versions
  • Past fiscal notes
  • Committee activity and documents
  • Bill History
Lobbyists Lobbyists
Votes House and Senate Votes
Vote Totals Vote Totals by Party
border   border
Copyright © 2019 State Capitol Watch